The team behind the vision

Nanocur was developed by Haus Bioceuticals Inc. Haus' highly integrated R&D team is comprised of multidisciplinary experts in the fields of naturopathic and allopathic medicine, immunology, and inflammatory biology.

Michael Centola, Ph.D. - CEO & Chief Scientific Officer at Nanocur

Michael Centola, Ph.D.

Chief Executive Officer & Chief Scientific Officer

Dr. Michael Centola is an immunologist and inflammatory disease expert with over 30 years of experience in turning cutting-edge science into real-world health solutions...
more ...

Philip Alex, M.D., Ph.D. - Chief Medical Officer at Nanocur

Philip Alex, M.D., Ph.D.

Chief Medical Officer

Dr. Philip Alex, M.D., Ph.D. obtained his Ph.D. in neuro-immunology and has over 20 years of experience in autoimmune, inflammatory, and translational research...
more ...

Christopher Sutton, Ph.D. - Vice President of Quality at Nanocur

Christopher Sutton, Ph.D.

Vice President of Quality

Dr. Christopher Sutton serves as Vice President of Quality for Nanocur, where he is responsible for production oversight, quality management systems...
more ...

Aniruddha Datta, M. Pharma., Ph.D. - VP International Operations at Nanocur

Aniruddha Datta, M. Pharma., Ph.D.

Vice President of International Operations

Dr. Datta oversees contract research and international manufacturing operations at Haus with a focus on herbal and nutraceutical product development...
more ...